Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979;7(Suppl 1):135S–138S. doi: 10.1111/j.1365-2125.1979.tb04683.x

Clobazam

Uncontrolled and standard controlled clinical trials

Thomas A Ban, M M Amin
PMCID: PMC1429520  PMID: 35196

Abstract

1 In an uncontrolled clinical trial, carried out in 11 psychiatric patients with the clinical diagnoses of anxiety neurosis and depressive neurosis, clobazam, a new benzodiazepine preparation, in the dosage range 10-60 mg daily produced statistically significant improvement in the total and both factor scores of the Hamilton Anxiety Scale (HAM-A). The lowest mean total HAM-A scores occurred with a mean clobazam dosage of 48 mg daily.

2 Results of the uncontrolled clinical trial were further substantiated in a standard-controlled clinical study in which no statistically significant difference between the therapeutic effectiveness of clobazam and diazepam could be revealed. The lowest mean total HAM-A scores occurred with a mean clobazam dosage of 49 mg daily. There was a lower incidence of adverse effects reported in patients receiving clobazam than in those taking the control drug (diazepam).

Full text

PDF
135S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barzaghi F., Fournex R., Mantegazza P. Pharmacological and toxicological properties of clobazam (1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3H-1,5-benzodiazepine), a new psychotherapeutic agent. Arzneimittelforschung. 1973 May;23(5):683–686. [PubMed] [Google Scholar]
  2. Borland R. G., Nicholson A. N. Immediate effects on human performance of a 1,5-genzodiazepine (clobazam) compared with the 1,4-benzodiazepines, chlordiazepoxide hydrochloride and diazepam. Br J Clin Pharmacol. 1975 Jun;2(3):215–221. doi: 10.1111/j.1365-2125.1975.tb01578.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Sandler K., Brunswick D., Digiacomo J., Mendels J. A preliminary evaluation of the anxiolytic activity of clobazam. Curr Ther Res Clin Exp. 1977 Jan;21(1):114–116. [PubMed] [Google Scholar]
  4. Snaith R. P., Bridge G. W., Hamilton M. The Leeds scales for the self-assessment of anxiety and depression. Br J Psychiatry. 1976 Feb;128:156–165. doi: 10.1192/bjp.128.2.156. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES